Church & Dwight delivered solid Q4 2025 results with revenue growth, strong margin expansion, and double-digit adjusted EPS growth, offset by weaker organic sales due to category softness and the exit of its vitamin business.
Revenue grew driven by international and specialty products performance
Adjusted EPS increased despite lower reported EPS
Gross margin expanded meaningfully year over year
International business delivered strong organic growth
Management expects industry-leading organic sales growth and margin expansion in 2026 despite the impact of exited businesses.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance